1 Introduction Ovarian cancer (OvCa) has the highest mortality rate among all gynaecological malignancies. Despite decades of research, death rates have only marginally declined in some countries. Late-stage diagnosis remains a challenge and therefore there is a critical need to develop improved treatment strategies alongside early detection technology [1]. Cell lines are a fundamental tool in understanding key biological mechanisms and testing therapeutic strategies in cancer.